158
Participants
Start Date
August 8, 2017
Primary Completion Date
August 27, 2020
Study Completion Date
December 1, 2020
Emtricitabine / Tenofovir Disoproxil Oral Tablet
Open-label emtricitabine 200mg/tenofovir 300mg
PrEP support
HIV/STI testing and counseling, adherence counseling, medical exams, safety monitoring, short message system (SMS), ie text message, and peer support, panel management.
Bridge HIV, San Francisco Department of Public Health, San Francisco
Tom Waddell Urban Health Clinic, San Francisco
San Francisco Community Health Clinic, San Francisco
Castro-Mission Health Center, San Francisco
Tri-City Health Center, Fremont
San Francisco Department of Public Health
OTHER_GOV
University of California, San Francisco
OTHER
San Francisco Community Health Center
UNKNOWN
Tri-City Health Center
UNKNOWN
California HIV/AIDS Research Program
OTHER
Public Health Foundation Enterprises, Inc.
OTHER